Within the pharmaceuticals sector, emerging markets have overtaken the more established EU economies in spending. Governments across emerging markets are investing in infrastructure, funding services and encouraging the development of a domestic industry within their catchments.
Emerging markets will be an important contributor to pharmaceuticals sales growth over the next few years with much of this growth likely to be driven by Brazil, Russia, India, China, Mexico, and Turkey. Our area of focus within this sector is aligned to this trend as we have established existing networks within the supply and manufacturing functions across both the mature and developing markets. We draw from this to help our clients secure the best in class talent for their business needs.